Active, not recruitingPHASE2, PHASE3NCT03898479
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
Studying Alopecia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sun Pharmaceutical Industries, Inc.
- Intervention
- CTP-543(drug)
- Enrollment
- 1000 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2019 – 2027
Study locations (30)
- Total Skin and Beauty Dermatology Center, Birmingham, Alabama, United States
- Alliance Dermatology & MOHS Center, Phoenix, Arizona, United States
- Center for Dermatology and Plastic Surgery/CCT Research, Scottsdale, Arizona, United States
- Johnson Dermatology, Fort Smith, Arkansas, United States
- Northwest Arkansas Clinical Trials Center, PLLC, Rogers, Arkansas, United States
- Kern Research Inc., Bakersfield, California, United States
- Hope Clinical Research, Canoga Park, California, United States
- California Dermatology & Clinical Research Institute, Encinitas, California, United States
- University of California, Irvine, Irvine, California, United States
- Dermatology Research Associates, Los Angeles, California, United States
- Quest Dermatology Research, Northridge, California, United States
- Kaiser Permanente Northern California - Oakland, Oakland, California, United States
- Palmtree Clinical Research, Inc., Palm Springs, California, United States
- Stanford University School of Medicine - Medical Dermatology Clinic, Redwood City, California, United States
- Kaiser Permanente South Sacramento, Sacramento, California, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03898479 on ClinicalTrials.govOther trials for Alopecia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07533006A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)Eli Lilly and Company
- RECRUITINGPHASE3NCT07435012Androgenic Alopecia TH07 Clinical TrialTriple Hair Inc
- ENROLLING BY INVITATIONNCT07499713Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia AreataIstanbul Training and Research Hospital
- RECRUITINGNANCT07422376Evaluation of Scalp Cooling During Chemotherapy on Quality of Life and the Potential Role of Single Nucleotide Variations on Chemotherapy-Induced Alopecia and Hair Regrowth in the Appalachian Highlands RegionCharles Mays
- RECRUITINGNCT07226531Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the USPfizer
- RECRUITINGNANCT07563036JAK2 Expression in Androgenetic Alopecia Before and After Topical MinoxidilKasr El Aini Hospital
- RECRUITINGPHASE2NCT07370519Topical Application of Lactobacillus Reuteri for Androgenetic AlopeciaShenzhen People's Hospital
- ACTIVE NOT RECRUITINGNANCT07520019Study Evaluating the Effect of Nutra Harmony "Biotin, Collagen and Keratin Beauty Complex" Dietary Supplement on Hair Thickness and Hair Strength in Adults With Self-Perceived Thinning HairNutra Harmony LLC